Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Licenses Pathways Analysis Technology to Stanford Genome Center

NEW YORK, Nov. 3 (GenomeWeb News) - Ingenuity has licensed its Pathways Analysis technology to the Stanford Genome Technology Center, the company said today.

 

The Pathways Analysis system maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.

 

Ron Davis, the director of the Stanford Genome Center, first used the software in beta release, the company said. Davis' lab is collaborating with Ingenuity, of Mountain View, Calif., on developing new functionality to extend its capabilities.

 

Ingenuity has also recently licensed its  Pathways Knowledge database to GlaxoSmithKline, and has signed a software distribution deal with Affymetrix, an investor in the company.



 

 

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.